Status:
UNKNOWN
Comparative Analysis of Large Macular Hole Surgeries
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Macular Holes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study compares the anatomical and visual outcomes in a large series of patients affected by idiopathic macular holes larger than 400 µm treated using pars plana vitrectomy and gas tamponade combi...
Detailed Description
Vitrectomy is the standard treatment for idiopathic macular holes (IMHs) and is combined with removal of the internal limiting membrane (ILM) to improve anatomical outcomes.However, surgical closure i...
Eligibility Criteria
Inclusion
- idiopathic MHs, a minimum hole diameter of ≥ 400 μm, and follow-up for at least 3 months after vitrectomy.
Exclusion
- High myopia (≥6 diopters,AL≥26.5mm), increased intraocular pressure (IOP, \>21 mm Hg) or glaucoma, severe cataract, severe systemic conditions that prevent surgery, and history of ocular trauma, intraocular inflammation, retinal vascular disease, or previous ocular surgery.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04116892
Start Date
May 1 2019
End Date
September 30 2021
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China